I. Galeraud-denis et al., Inhibitory effect of plasma obtained from hypophysectomized and control women on the assay of bioactive luteinizing hormone, HUM REPR, 14(2), 1999, pp. 312-317
The purpose of this study was to determine the effect of components of fema
le plasma on the value of bioactive luteinizing hormone (LH), especially in
the presence of low immunological LH value. Using both an immunoradiometri
c assay (IRMA) and rat Leydig cell bioassay, immunoreactive (I) and bioacti
ve (B) LH were assessed in plasma collected from women during a gonadotroph
in releasing hormone (GnRH) test performed on day 7 of a spontaneous cycle.
Two modes of response to an acute administration of GnRH were defined: nor
mal production of gonadotrophins (group I) and excessive secretion (group I
I) associated with a significant difference in the B/I-LH ratio between the
two groups. The B/I-LH ratio did not vary with sampling time during the te
st in either group. The addition of LH-free plasma collected from hypophyse
ctomized women caused a 30% decrease in testosterone production compared to
control values (in the presence or absence of hLH standard). A partial res
toration of testosterone production was observed if plasma was first treate
d with PEG 12%. The inhibitory factor(s) was also present in plasma from ov
ulatory women, even after treatment by an antibody against the entire LH mo
lecule. The effect of normal (A) or low I-LH plasma (B) on testosterone pro
duction varied strongly according to the plasma volume added to the bioassa
y, as well as to plasma treatments. Diethylether treatment caused a 50% dec
rease in testosterone secretion for plasma B (but not for A) whereas a dimi
nution of the steroidogenesis is observed after a PEG treatment of plasma A
(but not for B), suggesting that different inhibitory factors are present
in plasmas A and B. Therefore the LH bioactivity measured in the rat Leydig
cell assay, in terms of testosterone output, seems to represent a balance
between the LH molecule and the presence of inhibitory factors in the plasm
a.